{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:07:24Z","timestamp":1780394844804,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jacl.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T06:47:09Z","timestamp":1472626029000},"page":"1329-1337.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions"],"prefix":"10.1016","volume":"10","author":[{"given":"Katrina L.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dick C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damon A.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2016.08.011_bib1","first-page":"3478","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur\u00a0Heart J"},{"key":"10.1016\/j.jacl.2016.08.011_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2015.03.027","article-title":"Prevalence and treatment of familial hypercholesterolaemia in Australian communities","volume":"185","author":"Watts","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL-C genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from six countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2016.08.011_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOL.0000000000000090","article-title":"The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes","volume":"25","author":"Talmud","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2016.08.011_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2016.08.011_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrendo.2016.69","article-title":"Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism","volume":"12","author":"Ellis","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2016.08.011_bib7","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI107332","article-title":"Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia","volume":"52","author":"Goldstein","year":"1973","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2016.08.011_bib8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2012.15","article-title":"The genetics of familial combined hyperlipidaemia","volume":"8","author":"Brouwers","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2016.08.011_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.0000081777.17879.85","article-title":"Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study","volume":"108","author":"Hopkins","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2016.08.011_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1172\/JCI116544","article-title":"Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance","volume":"92","author":"Castro Cabezas","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2016.08.011_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.ATV.17.4.748","article-title":"Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia","volume":"17","author":"Aitman","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/01.ATV.0000160612.18065.29","article-title":"Role of insulin resistance in familial combined hyperlipidemia","volume":"25","author":"Veerkamp","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/hq0202.104059","article-title":"Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study","volume":"22","author":"Veerkamp","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib14","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/01.CIR.0000130646.93255.86","article-title":"Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study","volume":"109","author":"Veerkamp","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2016.08.011_bib15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jacl.2016.08.011_bib16","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2016.08.011_bib17","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2013.06.051","article-title":"Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL\/High Triglyceride and Impact on Global Health Outcomes)","volume":"62","author":"Albers","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2016.08.011_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib20","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2016.08.011_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9149(00)01429-6","article-title":"Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia","volume":"87","author":"Hopkins","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib23","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1136\/hrt.2003.022764","article-title":"Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia","volume":"90","author":"Neil","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jacl.2016.08.011_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2796.2003.01070.x","article-title":"Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia","volume":"253","author":"de Sauvage Nolting","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2016.08.011_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00041433-200404000-00009","article-title":"Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity","volume":"15","author":"Koschinsky","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2016.08.011_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: A model of care for Australasia","volume":"12","author":"Watts","year":"2011","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.jacl.2016.08.011_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.atherosclerosis.2012.07.030","article-title":"Genetic analysis of familial hypercholesterolaemia in Western Australia","volume":"224","author":"Hooper","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.08.011_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.jacl.2016.08.011_bib29","doi-asserted-by":"crossref","first-page":"3C","DOI":"10.1016\/S0002-9149(03)00003-1","article-title":"Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups","volume":"91","author":"Blasetto","year":"2003","journal-title":"Am\u00a0J\u00a0Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0002-9149(02)02994-6","article-title":"Comparative effects of rosuvastatin and atorvastatin\u00a0across their dose ranges in patients with hypercholesterolemia and without active arterial disease","volume":"91","author":"Schneck","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib31","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.clinthera.2004.09.006","article-title":"Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios\u00a0in patients with hypercholesterolemia: additional results from the STELLAR trial","volume":"26","author":"Jones","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.jacl.2016.08.011_bib32","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2009.08.651","article-title":"Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER)","volume":"105","author":"Nicholls","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib33","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1161\/01.CIR.0000068312.21969.C8","article-title":"Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial","volume":"107","author":"Ballantyne","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2016.08.011_bib34","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2004.02.060","article-title":"Efficacy\u00a0and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia","volume":"93","author":"Ballantyne","year":"2004","journal-title":"Am\u00a0J Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.atherosclerosis.2006.11.037","article-title":"Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)","volume":"192","author":"McKenney","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.08.011_bib36","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1345\/aph.1D391","article-title":"Approximate equivalent rosuvastatin doses for temporary statin interchange programs","volume":"38","author":"Kendrach","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacl.2016.08.011_bib37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.cca.2011.05.036","article-title":"Lipoprotein(a)-cholesterol: A significant component of serum cholesterol","volume":"412","author":"Kinpara","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2016.08.011_bib38","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1093\/hmg\/ddh069","article-title":"Genetics of familial combined hyperlipidemia and risk of coronary heart disease","volume":"13","author":"Shoulders","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jacl.2016.08.011_bib39","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0140-6736(73)91598-5","article-title":"Family study of serum lipids and lipoproteins in coronary heart-disease","volume":"301","author":"Nikkil\u00e4","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2016.08.011_bib40","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1161\/01.ATV.0000222907.72985.0b","article-title":"Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia","volume":"26","author":"Marcil","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib41","first-page":"892","article-title":"The Gln223Arg polymorphism in the leptin receptor is associated with familial combined hyperlipidemia","volume":"30","author":"van der Vleuten","year":"2006","journal-title":"Int\u00a0J\u00a0Obes (Lond)"},{"key":"10.1016\/j.jacl.2016.08.011_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2010.08.055","article-title":"Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia","volume":"213","author":"Nanni","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.08.011_bib43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2362.2001.00813.x","article-title":"The hormone sensitive lipase gene in familial combined hyperlipidemia and insulin resistance","volume":"31","author":"Pihlajamaki","year":"2001","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacl.2016.08.011_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1096-7192(03)00138-0","article-title":"Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia","volume":"80","author":"Eurlings","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jacl.2016.08.011_bib45","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1161\/ATVBAHA.112.245639","article-title":"Potential role of upstream stimulatory factor 1 gene variant in familial combined hyperlipidemia and related disorders","volume":"32","author":"Auer","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng1320","article-title":"Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1)","volume":"36","author":"Pajukanta","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2016.08.011_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2012.03.011","article-title":"Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia","volume":"222","author":"Solanas-Barca","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.08.011_bib48","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1253\/circj.70.1606","article-title":"Apolipoprotein E polymorphism influences lipid phenotypes in Chinese families with familial combined hyperlipidemia","volume":"70","author":"Pei","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.jacl.2016.08.011_bib49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00109-009-0490-z","article-title":"OSBPL10, a novel candidate gene for high triglyceride trait in dyslipidemic Finnish subjects, regulates cellular lipid metabolism","volume":"87","author":"Perttila","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.jacl.2016.08.011_bib50","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCGENETICS.109.908004","article-title":"Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples","volume":"3","author":"Weissglas-Volkov","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacl.2016.08.011_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.ATV.0000099881.83261.D4","article-title":"Linkage and association between distinct variants of the APOA1\/C3\/A4\/A5 gene cluster and familial combined hyperlipidemia","volume":"24","author":"Eichenbaum-Voline","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0021-9150(99)00428-1","article-title":"The V73M mutation in the hepatic\u00a0lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia","volume":"151","author":"Hoffer","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2016.08.011_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-511X-8-12","article-title":"Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene","volume":"8","author":"Lopez-Ruiz","year":"2009","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jacl.2016.08.011_bib54","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.jacc.2008.06.050","article-title":"Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting","volume":"52","author":"Civeira","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib55","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jmg.2008.059980","article-title":"A PCSK9 variant and familial combined hyperlipidaemia","volume":"45","author":"Abifadel","year":"2008","journal-title":"J Med Genet"},{"key":"10.1016\/j.jacl.2016.08.011_bib56","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1161\/ATVBAHA.108.180240","article-title":"The ATF6-Met[67]Val substitution is associated with increased plasma cholesterol levels","volume":"29","author":"Meex","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib57","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ajhg.2013.10.019","article-title":"Joint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia","volume":"93","author":"Rosenthal","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jacl.2016.08.011_bib58","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/eurheartj\/ehp051","article-title":"Familial-combined hyperlipidaemia in very young myocardial infarction survivors (< or\u00a0=40 years of age)","volume":"30","author":"Wiesbauer","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2016.08.011_bib59","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1161\/01.CIR.85.6.2025","article-title":"Familial lipoprotein disorders in patients with premature coronary artery disease","volume":"85","author":"Genest","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2016.08.011_bib60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.ATV.16.6.713","article-title":"Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease","volume":"16","author":"Kraft","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2016.08.011_bib61","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2016.08.011_bib62","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","article-title":"Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants","volume":"55","author":"Erqou","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib63","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2016.08.011_bib64","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","article-title":"Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease","volume":"43","author":"Schunkert","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2016.08.011_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijcard.2013.11.025","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"171","author":"Watts","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2016.08.011_bib66","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","article-title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","volume":"386","author":"Tsimikas","year":"2015","journal-title":"Lancet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416302847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416302847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:29:07Z","timestamp":1601054947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287416302847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1933287416302847"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2016.08.011","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}